Overview
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 976 days for 2020).
- 2024not filed
- 202304/07/2025
- 202217/06/2024
- 202117/06/2024
- 202017/06/2024
- 201920/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2023.
Results vs industry
Industry
Authorized Representatives
Manner of representation
In the case of a one-person management board, declarations of will on behalf of the company are made by a member of the management board. In the case of a management board consisting of two or more persons, joint action of two members of the management board or of one member of the management board jointly with a commercial proxy is required to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Monika Magdalena Konarska age 49 | 5 | $135.06 | 10% |
| 43 | $1,161.53 | 86% | |
Others | 2 | $54.02 | 4% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
19 public aid cases recorded, with a total value of $1,214,257.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Nov 7, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $8,621$8,621 | Marszałek Województwa Dolnośląskiego | |
| Sep 29, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $27,413$27,413 | Marszałek Województwa Dolnośląskiego | |
| Sep 9, 2025 | De minimis aid (in accordance with Commission Regulation 2023/2831) | $1,249$1,249 | Investin sp. z o.o. |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2021-07-01 | UroFlow – a device for the automatic diagnosis of prostate enlargement in men while urinating in a urinal | $394.3K$394,305 | Operational Programme Smart Growth | |
| 2020-11-01 | Promotion on foreign markets of the CoolMen medical device supporting the treatment of male infertility. | $105.8K$105,789 | Operational Programme Smart Growth | |
| 2017-07-03 | Coolmen - an innovative device supporting the treatment of male infertility. | $675.2K$675,205 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Inmed S.A. | $13,860,648.96 | inmed.pl | ||
| Zakład Optyczny Oculus sp. z o.o. | $332,546.80 | oculus.com.pl | ||
| Platinum sp. z o.o. | $313,097.87 | platinum-klinika.pl | ||
| Markdent sp. z o.o. | $129,752.97 | mark-dent.pl | ||
| K&J Polska sp. z o.o. | $70,953.51 | kjpolska.pl | ||
| Hemolens Diagnostics sp. z o.o. | $37,964.68 | hemolens.com | ||
| Pragma System Global sp. z o.o. | $34,880.66 | pragma.systems | ||
| Selex Polska sp. z o.o. | $7,765.44 | selexpolska.com | ||
| Hetalox sp. z o.o. | $965.71 | hetalox.com | ||
| Spinetime Solutions sp. z o.o. | – | spinetime.eu |
Change history
FAQ
Last updated: 2026-04-16
